Oric Pharmaceuticals, Inc. (ORIC) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $45.67M | -23.1% |
| 2024 | $59.41M | +154.0% |
| 2023 | $23.38M | -65.0% |
| 2022 | $66.84M | -70.4% |
| 2021 | $226.01M | +188.1% |
| 2020 | $78.45M | -12.0% |
| 2019 | $89.16M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $45.67M | -23.1% |
| 2024 | $59.41M | +154.0% |
| 2023 | $23.38M | -65.0% |
| 2022 | $66.84M | -70.4% |
| 2021 | $226.01M | +188.1% |
| 2020 | $78.45M | -12.0% |
| 2019 | $89.16M | — |